EMD Millipore Announces New Leadership of Bioscience Business Unit

May 25, 2012 -- May 25, 2012, Billerica, MA--EMD Millipore, the Life Science division of Merck KGaA of Darmstadt, Germany, announced today that John Sweeney, Head of the Life Science Business Field at EMD Millipore has been appointed Head of the company’s Bioscience Business Unit. In this capacity, he will be responsible for driving the strategic direction of the Bioscience Business Unit, as well as managing the day-to-day operations of the business fields encompassed within the Unit, which include Life Science and Discovery and Development Solutions. Sweeney succeeds Jon DiVincenzo.

“John’s experience, leadership and keen understanding of the life science markets will add significant value to the leadership team and our organization,” said Robert Yates, President of EMD Millipore. “His demonstrated success and expertise will offer new insights and perspectives for continued growth and opportunity within the Bioscience business.”

Sweeney joined Millipore Corporation in 2003 in Strategy and Corporate Development, and has held oppositions of increasing responsibility include Vice President of Strategy and Marketing Services. He holds a B.A. in Economics from the University of Pennsylvania and MBA from the Tuck School of Business at Dartmouth College.

About EMD Millipore

EMD Millipore is the Life Science division of Merck KGaA of Germany and offers a broad range of innovative, performance products, services and business relationships that enable our customers' success in research, development and production of biotech and pharmaceutical drug therapies. Through dedicated collaboration on new scientific and engineering insights, and as one of the top three R&D investors in the Life Science Tools industry, EMD Millipore serves as a strategic partner to customers and helps advance the promise of life science.

Headquartered in Billerica, Massachusetts, the division has around 10,000 employees, operations in 67 countries and 2011 revenues of EUR 2.4 billion. EMD Millipore is known as Merck Millipore outside of the U.S. and Canada.

Note: Merck KGaA or Merck shall mean Merck KGaA, Darmstadt, Germany

About Merck

All Merck Press Releases are distributed by e-mail at the same time they become available on the Merck Website. Please go to http://www.merck.de/subscribe to register online, change your selection or discontinue this service.

Merck is a global pharmaceutical and chemical company with total revenues of € 10.3 billion in 2011, a history that began in 1668, and a future shaped by more than 40,000 employees in 67 countries. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.